Darci Lamontagne
Nurse Practitioner · Cleburne, TXNPI 1649451303
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $876 and has fallen 53.9% since, to $404 in 2025.
Across 108 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$413
- Ironshore Pharmaceuticals Inc.$384
- GM Pharmaceuticals, Inc.$384
- GSK$182
- Cranial Technologies, Inc$125
- Adlon Therapeutics L.p.$108
- plus $834 from 18 others
What the payments were for
- Food & beverage$2,430100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 19 | $413 |
| Ironshore Pharmaceuticals Inc. | 19 | $384 |
| GM Pharmaceuticals, Inc. | 1 | $384 |
| GSK | 10 | $182 |
| Cranial Technologies, Inc | 8 | $125 |
| Adlon Therapeutics L.p. | 6 | $108 |
| Pfizer | 6 | $107 |
| Tris Pharma Inc | 6 | $107 |
| Supernus Pharmaceuticals, Inc. | 4 | $95 |
| Collegium Pharmaceutical, Inc. | 4 | $75 |
| Sanofi-aventis U.S. LLC | 3 | $57 |
| Merck | 3 | $53 |
| Seqirus USA Inc | 3 | $51 |
| Krystal Biotech Inc | 2 | $40 |
| Acadia Pharmaceuticals Inc | 2 | $39 |
| Sanofi Pasteur Inc. | 2 | $39 |
| Verrica Pharmaceuticals Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Cipher Pharmaceuticals US LLC | 1 | $25 |
| Biomarin Pharmaceutical Inc. | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $14 |
| LNHC, Inc | 1 | $14 |
| Abbott | 1 | $13 |
| Sobi, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vanacof$384
How this compares
$2,430 in reported general payments places this provider in the 85th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Cleburne
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Onna FeuchterSouthlake$108K
- Stephanie AgrellaRound Rock$102K
- Sue RankinAmarillo$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.